- Helps control elevated blood sugar levels in adults with type 2 diabetes mellitus.
- Combines the complementary blood glucose-lowering actions of sitagliptin and dapagliflozin.
- Sitagliptin helps improve glucose-dependent insulin release and reduce excessive glucagon secretion.
- Dapagliflozin helps the kidneys remove excess glucose from the body through urine.
- May improve blood glucose control when diet and exercise alone are not sufficient.
- May help control both fasting and post-meal blood glucose levels.
- Can be prescribed when combination therapy is considered appropriate by a healthcare professional.
- Consistent blood sugar control may help reduce the risk of diabetes-related complications over time.
- May contribute to modest weight loss in some patients because dapagliflozin promotes urinary glucose loss.
- Works best when combined with appropriate diet, regular physical activity, and blood glucose monitoring.
Sitara D 50/5 mg Tablet - Strip of 10
Compositions : Dapagliflozin 5mg + Sitagliptin 50mg
MRP :
MRP :
In stock
Delivery within 2 to 7 Working Days
Manufacture/Marketer: Intas Pharmaceuticals Ltd.
Door Step Delivery
Quick and Secure
No Hidden Charges
Pay only what's shown
18K Pincodes Served
With Trust & Reliability
Description
Sitara D 50/5 mg Tablet is a prescription medicine used to help control blood sugar levels in adults with type 2 diabetes mellitus. It contains two active ingredients, Sitagliptin 50 mg and Dapagliflozin 5 mg, which work through different mechanisms to improve blood glucose control. Sitagliptin belongs to the DPP-4 inhibitor group and helps increase glucose-dependent insulin release while reducing glucagon secretion when blood sugar levels are elevated. Dapagliflozin belongs to the SGLT2 inhibitor group and helps the kidneys remove excess glucose from the body through urine. Together, these medicines provide complementary blood sugar-lowering effects and may be prescribed when additional glucose control is needed along with diet and exercise.
The main purpose of Sitara D 50/5 mg Tablet is to help maintain blood glucose within the target range and reduce the long-term risks associated with poorly controlled type 2 diabetes. It is generally used as part of an overall diabetes-management plan that includes a balanced diet, regular physical activity, and monitoring of blood sugar. Patients should take this medicine exactly as prescribed and should not change the dose or stop treatment without consulting their doctor.
Most people can take Sitara D 50/5 mg Tablet when prescribed appropriately, but some may experience side effects. Common side effects may include increased urination, nausea, headache, diarrhoea, or symptoms related to dehydration. Dapagliflozin can increase the risk of urinary tract infections and genital fungal infections. The risk of low blood sugar is generally low when the combination is used alone but may increase when used with insulin or sulfonylureas.
Product Details
- Sitara D 50/5 mg Tablet contains Sitagliptin and Dapagliflozin, which lower blood glucose through two different mechanisms.
- Sitagliptin inhibits the DPP-4 enzyme, helping incretin hormones remain active for longer.
- This increases glucose-dependent insulin release and decreases glucagon secretion when blood glucose is elevated.
- Dapagliflozin inhibits SGLT2 in the kidneys, reducing the reabsorption of filtered glucose.
- As a result, more glucose is eliminated through urine, helping reduce blood glucose levels.
- The complementary actions of both ingredients provide additional glucose control when a single mechanism is insufficient.
- Take Sitara D 50/5 mg Tablet exactly as prescribed by your doctor.
- Swallow the tablet whole with a glass of water.
- Do not crush, chew, or break the tablet unless your doctor specifically instructs you otherwise.
- It can generally be taken with or without food.
- Try to take Sitara D 50/5 mg Tablet at approximately the same time each day to maintain a consistent treatment routine.
- Drink adequate fluids unless your doctor has advised you to restrict fluid intake, as dapagliflozin can increase fluid loss through urination.
- If you miss a dose, take it when you remember unless it is nearly time for your next dose. Do not take two doses together to make up for a missed dose.
- Do not stop taking Sitara D 50/5 mg Tablet on your own even if your blood sugar improves. Consult your doctor before changing or discontinuing treatment.
- Follow a balanced diabetes-friendly diet and limit foods and drinks containing excessive added sugar.
- Exercise regularly according to your doctor's recommendations.
- Drink adequate water to help reduce the risk of dehydration, particularly if you urinate more frequently.
- Monitor your blood glucose as recommended by your healthcare professional.
- Limit alcohol because it can contribute to blood sugar fluctuations and dehydration.
- Maintain good personal hygiene, particularly around the genital area, because increased glucose in the urine may increase the risk of genital fungal infections.
- Attend regular medical appointments so your doctor can monitor blood sugar, kidney function, and other relevant health parameters.
Safety Advice
Side Effects
- Common side effects may include increased urination, nausea, headache, diarrhoea, or symptoms associated with dehydration.
- Dapagliflozin may increase the risk of urinary tract infections and genital fungal infections.
- Some patients may experience dizziness or weakness, particularly if excessive fluid is lost.
- Low blood sugar may occur, especially when Sitara D 50/5 mg Tablet is used together with insulin or a sulfonylurea.
- Rare but serious symptoms such as persistent vomiting, severe abdominal pain, unusual weakness, difficulty breathing, or confusion require prompt medical attention.
- If you experience persistent or troublesome side effects, contact your healthcare provider for advice.
Precautions and Warnings
- Inform your doctor if you have kidney or liver problems before starting Sitara D 50/5 mg Tablet.
- This medicine is not intended for the treatment of type 1 diabetes mellitus or diabetic ketoacidosis.
- Patients taking diuretics or medicines that affect kidney function should inform their doctor because dapagliflozin may increase the risk of dehydration or changes in kidney function.
- Inform your doctor if you have a history of recurrent urinary tract or genital infections.
- Pregnant or breastfeeding women should consult their healthcare provider before using Sitara D 50/5 mg Tablet.
- Maintain adequate fluid intake unless your doctor has advised fluid restriction.
- Tell your doctor about all medicines, supplements, and herbal products you are taking, particularly insulin and sulfonylureas.
- Seek urgent medical attention if you develop symptoms that may suggest diabetic ketoacidosis, such as severe nausea or vomiting, abdominal pain, unusual tiredness, confusion, or difficulty breathing, even if your blood glucose is not extremely high.
FAQs
Sitara D 50/5 mg Tablet is used with diet and exercise to help control blood sugar levels in adults with type 2 diabetes mellitus.
2. What are the ingredients in Sitara D 50/5 mg Tablet?
It contains Sitagliptin 50 mg and Dapagliflozin 5 mg.
3. Does Sitara D 50/5 mg Tablet cause low blood sugar?
When used alone, it generally has a low risk of causing hypoglycaemia. However, the risk may increase when it is used with insulin or medicines such as sulfonylureas.
4.Why may I urinate more often while taking Sitara D 50/5 mg Tablet?
Dapagliflozin increases the amount of glucose eliminated through urine, which can also increase urination. Maintaining adequate fluid intake can help reduce the risk of dehydration.
5. Can Sitara D 50/5 mg Tablet cause weight loss?
Some people may experience modest weight loss because dapagliflozin causes glucose and associated calories to be eliminated through urine. However, it should not be used specifically as a weight-loss medicine.
6.Can I take Sitara D 50/5 mg Tablet during pregnancy?
If you are pregnant, planning pregnancy, or become pregnant while taking this medicine, contact your doctor. Your doctor may recommend an alternative diabetes treatment.
7. Can I drink alcohol while taking Sitara D 50/5 mg Tablet?
It is advisable to limit or avoid alcohol and discuss alcohol consumption with your doctor because it may contribute to blood sugar fluctuations and dehydration.
8. What should I do if I forget to take Sitara D 50/5 mg Tablet?
Take the missed dose when you remember unless it is almost time for the next dose. Do not take two doses together to make up for a missed tablet.
Instructions
Directions for Use
Storage and Disposal
More Information
| SKU | 162268 |
|---|---|
| Country of Manufacture | India |
| Manufacturer Address | Intas Pharmaceuticals Ltd. |
| Return/Buy Back policy | Non-returnable |
| Prescription Required | Yes |
| Storage | Please refer to the product label for storage information. |
| Seller | Kogland Commerce Pvt Ltd (TN) |
Sitara D 50/5 mg Tablet is a prescription medicine used to help control blood sugar levels in adults with type 2 diabetes mellitus. It contains two active ingredients, Sitagliptin 50 mg and Dapagliflozin 5 mg, which work through different mechanisms to improve blood glucose control. Sitagliptin belongs to the DPP-4 inhibitor group and helps increase glucose-dependent insulin release while reducing glucagon secretion when blood sugar levels are elevated. Dapagliflozin belongs to the SGLT2 inhibitor group and helps the kidneys remove excess glucose from the body through urine. Together, these medicines provide complementary blood sugar-lowering effects and may be prescribed when additional glucose control is needed along with diet and exercise.
The main purpose of Sitara D 50/5 mg Tablet is to help maintain blood glucose within the target range and reduce the long-term risks associated with poorly controlled type 2 diabetes. It is generally used as part of an overall diabetes-management plan that includes a balanced diet, regular physical activity, and monitoring of blood sugar. Patients should take this medicine exactly as prescribed and should not change the dose or stop treatment without consulting their doctor.
Most people can take Sitara D 50/5 mg Tablet when prescribed appropriately, but some may experience side effects. Common side effects may include increased urination, nausea, headache, diarrhoea, or symptoms related to dehydration. Dapagliflozin can increase the risk of urinary tract infections and genital fungal infections. The risk of low blood sugar is generally low when the combination is used alone but may increase when used with insulin or sulfonylureas.
- Helps control elevated blood sugar levels in adults with type 2 diabetes mellitus.
- Combines the complementary blood glucose-lowering actions of sitagliptin and dapagliflozin.
- Sitagliptin helps improve glucose-dependent insulin release and reduce excessive glucagon secretion.
- Dapagliflozin helps the kidneys remove excess glucose from the body through urine.
- May improve blood glucose control when diet and exercise alone are not sufficient.
- May help control both fasting and post-meal blood glucose levels.
- Can be prescribed when combination therapy is considered appropriate by a healthcare professional.
- Consistent blood sugar control may help reduce the risk of diabetes-related complications over time.
- May contribute to modest weight loss in some patients because dapagliflozin promotes urinary glucose loss.
- Works best when combined with appropriate diet, regular physical activity, and blood glucose monitoring.
- Sitara D 50/5 mg Tablet contains Sitagliptin and Dapagliflozin, which lower blood glucose through two different mechanisms.
- Sitagliptin inhibits the DPP-4 enzyme, helping incretin hormones remain active for longer.
- This increases glucose-dependent insulin release and decreases glucagon secretion when blood glucose is elevated.
- Dapagliflozin inhibits SGLT2 in the kidneys, reducing the reabsorption of filtered glucose.
- As a result, more glucose is eliminated through urine, helping reduce blood glucose levels.
- The complementary actions of both ingredients provide additional glucose control when a single mechanism is insufficient.
- Take Sitara D 50/5 mg Tablet exactly as prescribed by your doctor.
- Swallow the tablet whole with a glass of water.
- Do not crush, chew, or break the tablet unless your doctor specifically instructs you otherwise.
- It can generally be taken with or without food.
- Try to take Sitara D 50/5 mg Tablet at approximately the same time each day to maintain a consistent treatment routine.
- Drink adequate fluids unless your doctor has advised you to restrict fluid intake, as dapagliflozin can increase fluid loss through urination.
- If you miss a dose, take it when you remember unless it is nearly time for your next dose. Do not take two doses together to make up for a missed dose.
- Do not stop taking Sitara D 50/5 mg Tablet on your own even if your blood sugar improves. Consult your doctor before changing or discontinuing treatment.
- Follow a balanced diabetes-friendly diet and limit foods and drinks containing excessive added sugar.
- Exercise regularly according to your doctor's recommendations.
- Drink adequate water to help reduce the risk of dehydration, particularly if you urinate more frequently.
- Monitor your blood glucose as recommended by your healthcare professional.
- Limit alcohol because it can contribute to blood sugar fluctuations and dehydration.
- Maintain good personal hygiene, particularly around the genital area, because increased glucose in the urine may increase the risk of genital fungal infections.
- Attend regular medical appointments so your doctor can monitor blood sugar, kidney function, and other relevant health parameters.
Side Effects
- Common side effects may include increased urination, nausea, headache, diarrhoea, or symptoms associated with dehydration.
- Dapagliflozin may increase the risk of urinary tract infections and genital fungal infections.
- Some patients may experience dizziness or weakness, particularly if excessive fluid is lost.
- Low blood sugar may occur, especially when Sitara D 50/5 mg Tablet is used together with insulin or a sulfonylurea.
- Rare but serious symptoms such as persistent vomiting, severe abdominal pain, unusual weakness, difficulty breathing, or confusion require prompt medical attention.
- If you experience persistent or troublesome side effects, contact your healthcare provider for advice.
Precautions and Warnings
- Inform your doctor if you have kidney or liver problems before starting Sitara D 50/5 mg Tablet.
- This medicine is not intended for the treatment of type 1 diabetes mellitus or diabetic ketoacidosis.
- Patients taking diuretics or medicines that affect kidney function should inform their doctor because dapagliflozin may increase the risk of dehydration or changes in kidney function.
- Inform your doctor if you have a history of recurrent urinary tract or genital infections.
- Pregnant or breastfeeding women should consult their healthcare provider before using Sitara D 50/5 mg Tablet.
- Maintain adequate fluid intake unless your doctor has advised fluid restriction.
- Tell your doctor about all medicines, supplements, and herbal products you are taking, particularly insulin and sulfonylureas.
- Seek urgent medical attention if you develop symptoms that may suggest diabetic ketoacidosis, such as severe nausea or vomiting, abdominal pain, unusual tiredness, confusion, or difficulty breathing, even if your blood glucose is not extremely high.
Sitara D 50/5 mg Tablet is used with diet and exercise to help control blood sugar levels in adults with type 2 diabetes mellitus.
2. What are the ingredients in Sitara D 50/5 mg Tablet?
It contains Sitagliptin 50 mg and Dapagliflozin 5 mg.
3. Does Sitara D 50/5 mg Tablet cause low blood sugar?
When used alone, it generally has a low risk of causing hypoglycaemia. However, the risk may increase when it is used with insulin or medicines such as sulfonylureas.
4.Why may I urinate more often while taking Sitara D 50/5 mg Tablet?
Dapagliflozin increases the amount of glucose eliminated through urine, which can also increase urination. Maintaining adequate fluid intake can help reduce the risk of dehydration.
5. Can Sitara D 50/5 mg Tablet cause weight loss?
Some people may experience modest weight loss because dapagliflozin causes glucose and associated calories to be eliminated through urine. However, it should not be used specifically as a weight-loss medicine.
6.Can I take Sitara D 50/5 mg Tablet during pregnancy?
If you are pregnant, planning pregnancy, or become pregnant while taking this medicine, contact your doctor. Your doctor may recommend an alternative diabetes treatment.
7. Can I drink alcohol while taking Sitara D 50/5 mg Tablet?
It is advisable to limit or avoid alcohol and discuss alcohol consumption with your doctor because it may contribute to blood sugar fluctuations and dehydration.
8. What should I do if I forget to take Sitara D 50/5 mg Tablet?
Take the missed dose when you remember unless it is almost time for the next dose. Do not take two doses together to make up for a missed tablet.
Directions for Use
Storage and Disposal
| SKU | 162268 |
|---|---|
| Country of Manufacture | India |
| Manufacturer Address | Intas Pharmaceuticals Ltd. |
| Return/Buy Back policy | Non-returnable |
| Prescription Required | Yes |
| Storage | Please refer to the product label for storage information. |
| Seller | Kogland Commerce Pvt Ltd (TN) |
Door Step Delivery
Quick and Secure
No Hidden Charges
Pay only what's shown
18K Pincodes Served
With Trust & Reliability
Customer Reviews
No reviews yet
Be the first to share your thoughts. Honest feedback helps other shoppers and us serve you better.
Write Your Own Review
Only registered users can write reviews. Please Sign in or create an account